Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications

Giovanni Donato Aquaro1, Elisabetta Corsi2, Giancarlo Todiere1

  • 1Fondazione Toscana G. Monasterio, 56124 Pisa, Italy.

Insights

Cardiac magnetic resonance (CMR) significantly alters diagnoses for left ventricular hypertrophy (LVH) initially suspected via echocardiography or ECG. This advanced imaging improves diagnostic accuracy and reassesses patient prognosis, particularly for hypertrophic cardiomyopathy.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Diagnostic Medicine

Background:

  • Left ventricular hypertrophy (LVH) presents diverse etiologies, from secondary forms to severe cardiomyopathies.
  • Transthoracic Echocardiography (TTE) and Electrocardiography (ECG) are primary tools for LVH diagnosis.
  • Cardiac Magnetic Resonance (CMR) offers precise characterization of LVH type, extent, and severity.

Purpose of the Study:

  • To assess the diagnostic and prognostic utility of CMR in patients with suspected LVH.
  • To evaluate CMR's role in refining diagnoses made by TTE and/or ECG.

Main Methods:

  • CMR imaging was performed on 300 consecutive patients exhibiting TTE and/or ECG signs of LVH.
  • Diagnostic discrepancies between initial TTE suspicion and final CMR diagnosis were analyzed.

Main Results:

  • CMR altered the initial diagnosis in 42.7% of patients, significantly increasing hypertrophic cardiomyopathy (HCM) detection.
  • CMR successfully diagnosed LVH in 82% of cases with initially undetermined TTE findings.
  • CMR identified HCM in 80% of patients with ECG criteria for LVH but normal echocardiography, and reclassification impacted survival risk assessment.

Conclusions:

  • CMR significantly reclassifies LVH diagnoses initially suggested by echocardiography, particularly identifying HCM.
  • CMR is crucial for characterizing LVH when detected by echocardiography or suspected via ECG.
  • The study underscores CMR's value in improving diagnostic accuracy and prognostic stratification for LVH.
Abstract

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
42
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
69
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
152
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
98